- Home
- WSFS vs ARWR Comparison
WSFS vs ARWR Comparison
Compare WSFS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSFS
- ARWR
- Stock Information
- Founded
- WSFS 1980
- ARWR 2003
- Country
- WSFS United States
- ARWR United States
- Employees
- WSFS N/A
- ARWR N/A
- Industry
- WSFS Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- WSFS Finance
- ARWR Health Care
- Exchange
- WSFS Nasdaq
- ARWR Nasdaq
- Market Cap
- WSFS 3.1B
- ARWR 1.8B
- IPO Year
- WSFS N/A
- ARWR 1993
- Fundamental
- Price
- WSFS $57.62
- ARWR $17.64
- Analyst Decision
- WSFS Hold
- ARWR Buy
- Analyst Count
- WSFS 4
- ARWR 8
- Target Price
- WSFS $61.00
- ARWR $43.71
- AVG Volume (30 Days)
- WSFS 371.9K
- ARWR 1.6M
- Earning Date
- WSFS 07-24-2025
- ARWR 08-07-2025
- Dividend Yield
- WSFS 1.15%
- ARWR N/A
- EPS Growth
- WSFS N/A
- ARWR N/A
- EPS
- WSFS 4.44
- ARWR N/A
- Revenue
- WSFS $987,714,000.00
- ARWR $545,209,000.00
- Revenue This Year
- WSFS N/A
- ARWR $22,384.93
- Revenue Next Year
- WSFS $3.45
- ARWR N/A
- P/E Ratio
- WSFS $13.28
- ARWR N/A
- Revenue Growth
- WSFS 4.38
- ARWR 1436.97
- 52 Week Low
- WSFS $42.44
- ARWR $9.57
- 52 Week High
- WSFS $62.75
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- WSFS 63.88
- ARWR 68.77
- Support Level
- WSFS $57.24
- ARWR $18.10
- Resistance Level
- WSFS $59.07
- ARWR $19.07
- Average True Range (ATR)
- WSFS 1.42
- ARWR 0.79
- MACD
- WSFS 0.19
- ARWR 0.22
- Stochastic Oscillator
- WSFS 77.30
- ARWR 85.75
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.